CO-INFXN (babesia microti, bartonella henselae, borrelia burgdorferi nosode, ehrlichia nosode- canine, encephalitis nosode, myco

Nazione: Stati Uniti

Lingua: inglese

Fonte: NLM (National Library of Medicine)

Compra

Scheda tecnica Scheda tecnica (SPC)
31-08-2022

Principio attivo:

BABESIA MICROTI (UNII: 1948X6KEG3) (BABESIA MICROTI - UNII:1948X6KEG3), BARTONELLA HENSELAE (UNII: 84PG7W9845) (BARTONELLA HENSELAE - UNII:84PG7W9845), BORRELIA BURGDORFERI (UNII: 0J8NV9V5Q8) (BORRELIA BURGDORFERI - UNII:0J8NV9V5Q8), EHRLICHIA CANIS (UNII: 970Y8T1JZY) (EHRLICHIA CANIS - UNII:970Y8T1JZY), JAPANESE ENCEPHALITIS VIRUS (UNII: P07E7XWU9D) (JAPANESE ENCEPHALITIS VIRUS - UNII:P07E7XWU9D), MYCOPLASMA PNEUMONIAE (UNII: JQE470FAD0) (MYCOPLASMA PNEUMONIAE - UNII:JQE470FAD0), NEISSERIA MENINGITID

Commercializzato da:

Deseret Biologicals, Inc.

INN (Nome Internazionale):

BABESIA MICROTI

Composizione:

BABESIA MICROTI 15 [hp_X] in 1 mL

Via di somministrazione:

ORAL

Tipo di ricetta:

OTC DRUG

Indicazioni terapeutiche:

For the temporarily relief of symptoms related to Lyme disease or other co-infections including joint pain, severe headaches, fever, severe muscle aches/pain, flu-like feelings of headache, stiff neck, muscle aches, and change in smell/taste, difficulty chewing, swallowing or speaking, hoarseness of vocal cord problems.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration. For the temporarily relief of symptoms related to Lyme disease or other co-infections including joint pain, severe headaches, fever, severe muscle aches/pain, flu-like feelings of headache, stiff neck, muscle aches, and change in smell/taste, difficulty chewing, swallowing or speaking, hoarseness of vocal cord problems.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

Stato dell'autorizzazione:

unapproved homeopathic

Scheda tecnica

                                CO-INFXN- BABESIA MICROTI, BARTONELLA HENSELAE, BORRELIA BURGDORFERI
NOSODE,
EHRLICHIA NOSODE (CANINE), ENCEPHALITIS NOSODE, MYCOPLASMA PNEUMONIAE,
MENINGOCOCCUS NOSODE, HEPATITIS B NOSODE LIQUID
DESERET BIOLOGICALS, INC.
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug_
_Administration for safety or efficacy. FDA is not aware of scientific
evidence to support_
_homeopathy as effective._
----------
DRUG FACTS:
ACTIVE INGREDIENTS:
Babesia Microti 15X, 30X, 60X, 100X, 200X, Bartonella Henselae 15X,
30X, 60X, 100X,
200X, Borrelia Burgdorferi Nosode 15X, 30X, 60X, 100X, 200X, Ehrlichia
Nosode
(Canine) 15X, 30X, 60X, 100X, 200X, Encephalitis Nosode 15X, 30X, 60X,
100X, 200X,
Mycoplasma Pneumoniae 15X, 30X, 60X, 100X, 200X, Meningococcus Nosode
21X,
30X, 60X, 100X, 200X, Hepatitis B Nosode 15C, 30C, 60C, 100C, 200C.
HOMEOPATHIC INDICATIONS:
For the temporarily relief of symptoms related to Lyme disease or
other co-infections
including joint pain, severe headaches, fever, severe muscle
aches/pain, flu-like feelings
of headache, stiff neck, muscle aches, and change in smell/taste,
difficulty chewing,
swallowing or speaking, hoarseness of vocal cord problems.**
**These statements are based upon traditional homeopathic practice.
They have not
been reviewed by the Food and Drug Administration.
WARNINGS:
KEEP OUT OF REACH OF CHILDREN. In case of overdose, contact a
physician or Poison
Control Center right away.
IF PREGNANT OR BREAST-FEEDING, seek advice of a health professional
before use.
Tamper seal: "Sealed for Your Protection." Do not use if seal is
broken or missing.
KEEP OUT OF REACH OF CHILDREN:
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help
or contact a
Poison Control Center right away.
DIRECTIONS:
1-10 drops under the tongue, 3 times a day or as directed by a health
professional.
Consult a physician for use in children under 12 years of age.
HOMEOPATHIC INDICATIONS:
HOMEOPATHIC INDICATIONS:
For the temporarily relief of symptoms related to Lyme disease or
other 
                                
                                Leggi il documento completo